Peptide Therapeutics intermediate
Luspatercept - Anemia (NCT02631070)
Trial of luspatercept for anemia in myelodysplastic syndromes. This peptide or oligopeptide is studied for its biological activity, structure-activity relati...
By Encyclopeptide Editorial | 1 min read
luspatercept-anemia-nct02631070 peptide research
Overview
Trial of luspatercept for anemia in myelodysplastic syndromes.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Luspatercept - Anemia (NCT02631070)” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Luspatercept - Anemia (NCT02631070) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept